C4 Therapeutics Inc (CCCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 55,499 | 126,590 | 29,754 | 76,124 | 181,727 |
| Marketable Securities | 189,405 | 127,091 | 246,399 | 233,155 | 189,962 |
| Receivables | 3,102 | 11,799 | 1,473 | 5,716 | 4,484 |
| TOTAL | $257,767 | $271,189 | $287,557 | $325,689 | $381,009 |
| Non-Current Assets | |||||
| PPE Net | 5,842 | 7,132 | 7,400 | 3,108 | 3,323 |
| Investments And Advances | 22,359 | 28,008 | 60,962 | 142,200 | 0 |
| Other Non-Current Assets | 63,634 | 70,122 | 74,921 | 35,768 | 15,806 |
| TOTAL | $91,835 | $105,262 | $143,283 | $181,076 | $19,129 |
| Total Assets | $349,602 | $376,451 | $430,840 | $506,765 | $400,138 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 2,287 | N/A | N/A |
| Accounts payable and accrued liabilities | 1,328 | 1,446 | 1,172 | 4,506 | 5,683 |
| Accrued Expenses | 19,363 | 20,630 | 19,769 | 13,606 | 9,524 |
| TOTAL | $45,177 | $42,766 | $44,546 | $51,246 | $43,852 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 9,195 | 10,768 | 10,052 |
| Deferred Revenues | 18,712 | 15,471 | 16,618 | 31,800 | 27,603 |
| Other Non-Current Liabilities | 59,982 | 65,757 | 70,970 | 30,777 | 11,826 |
| TOTAL | $88,439 | $87,571 | $97,060 | $65,913 | $75,495 |
| Total Liabilities | $133,616 | $130,337 | $141,606 | $117,159 | $119,347 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 70,990 | 68,601 | 49,051 | 48,739 | 43,119 |
| Common Shares | 7 | 6 | 5 | 5 | 4 |
| Retained earnings | -633,699 | -528,383 | -395,890 | -267,715 | -183,823 |
| Other shareholders' equity | 53 | -127 | -4,137 | -775 | 13 |
| TOTAL | $215,986 | $246,114 | $289,234 | $389,606 | $280,791 |
| Total Liabilities And Equity | $349,602 | $376,451 | $430,840 | $506,765 | $400,138 |